Clinically Relevant Herb–Drug Interactions: A 30-Year Historical Assessment

References

• Abe O, Ono T, Sato H, Müller F, Ogata H, Miura I, Shikama Y, Yabe H, Onoue S, Fromm MF, et al. 2018. Role of (-)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers. Eur J Clin Pharmacol. 74(6):775–783. doi: 10.1007/s00228-018-2436-2.
   PubMed Web of Science ®Google Scholar
• Albassam AA, Markowitz JS. 2017. An appraisal of drug-drug interactions with green tea (Camellia sinensis). Planta Med. 83(6):496–508. doi: 10.1055/s-0043-100934.
   PubMed Web of Science ®Google Scholar
• Ames BN, Profet M, Gold LS. 1990. Dietary pesticides (99.99% all natural). Proc Natl Acad Sci USA. 87(19):7777–7781. doi: 10.1073/pnas.87.19.7777.
   PubMed Web of Science ®Google Scholar
• An G, Mukker JK, Derendorf H, Frye RF. 2015. Enzyme- and transporter-mediated beverage-drug interactions: an update on fruit juices and green tea. J Clin Pharmacol. 55(12):1313–1331. doi: 10.1002/jcph.563.
   PubMed Web of Science ®Google Scholar
• Arold G, Donath F, Maurer A, Diefenbach K, Bauer S, Henneicke-von Zepelin H-H, Friede M, Roots I. 2005. No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St. John’s wort extract. Planta Med. 71(4):331–337. doi: 10.1055/s-2005-864099.
   PubMed Web of Science ®Google Scholar
• Awortwe C, Bruckmueller H, Cascorbi I. 2019. Interaction of herbal products with prescribed medications: a systematic review and meta-analysis. Pharmacol Res. 141:397–408. doi: 10.1016/j.phrs.2019.01.028.
   PubMed Web of Science ®Google Scholar
• Bansal S, Zamarripa CA, Spindle TR, Weerts EM, Thummel KE, Vandrey R, Paine MF, Unadkat JD. 2023. Evaluation of cytochrome P450-mediated cannabinoid-drug interactions in healthy adult participants. Clin Pharmacol Ther. 114(3):693–703. doi: 10.1002/cpt.2973.
   PubMed Web of Science ®Google Scholar
• Barker WD, Anita U. 2007. A study of the use of Ephedra in the manufacture of methamphetamine. Forensic Sci Int. 166:102-109.
   Google Scholar
• Barone GW, Gurley BJ, Ketel BL, Lightfoot ML, Abul-Ezz SR. 2000. Drug interaction between St John’s wort and cyclosporine. Ann Pharmacother. 34(9):1013–1016. doi: 10.1345/aph.10088.
   PubMed Web of Science ®Google Scholar
• Bastaminejad S, Bakhtiyari S. 2021. Quercetin and its relative therapeutic potential against COVID-19: a retrospective review and prospective overview. Curr Mol Med. 21(5):385–391. doi: 10.2174/1566524020999200918150630.
   PubMed Web of Science ®Google Scholar
• Bedada SK, Nearati P. 2015. Effect of resveratrol on the pharmacokinetics of carbamazepine in healthy human volunteers. Phytother Res. 29(5):701–706. doi: 10.1002/ptr.5302.
   PubMed Web of Science ®Google Scholar
• Bedada SK, Neerati P. 2016. Resveratrol pretreatment affects CYP2E1 activity of chlorzoxazone in healthy human volunteers. Phytother Res. 30(3):463–468. doi: 10.1002/ptr.5549.
   PubMed Web of Science ®Google Scholar
• Bedada SK, Yellu NR, Neerati P. 2016. Effect of resveratrol treatment on the pharmacokinetics of diclofenac in healthy human volunteers. Phytother Res. 30(3):397–401. doi: 10.1002/ptr.5539.
   PubMed Web of Science ®Google Scholar
• Bedada SK, Appani R, Boga PK. 2017. Effect of piperine on the metabolism and pharmacokinetics of carbamazepine in healthy volunteers. Drug Res. 67(1):46–51.
   Web of Science ®Google Scholar
• Bedada SK, Neerati P. 2018a. Evaluation of the effect of quercetin treatment on CYP2C9 enzyme activity of diclofenac in healthy human volunteers. Phytother Res. 32(2):305–311. doi: 10.1002/ptr.5978.
   PubMed Web of Science ®Google Scholar
• Bedada SK, Neerati P. 2018b. The effect of quercetin on the pharmacokinetics of chlorzoxazone, a CYP2E1 substrate, in healthy subject. Eur J Clin Pharmacol. 74(1):91–97. doi: 10.1007/s00228-017-2345-9.
   PubMed Web of Science ®Google Scholar
• Beerhues L. 2006. Hyperforin. Phytochem. 67(20):2201–2207. doi: 10.1016/j.phytochem.2006.08.017.
   PubMed Web of Science ®Google Scholar
• Bonn-Miller MO, Loflin MJE, Thomas BF, Marcu JP, Hyke T, Vandrey R. 2017. Labeling accuracy of cannabidiol extracts sold online. JAMA. 318(17):1708–1709. doi: 10.1001/jama.2017.11909.
   PubMed Web of Science ®Google Scholar
• Borrelli F, Izzo AA. 2009. Herb-drug interactions with St John’s wort (Hypericum perforatum): an update on clinical observations. AAPS J. 11(4):710–727. doi: 10.1208/s12248-009-9146-8.
   PubMed Web of Science ®Google Scholar
• Brantley SJ, Argikar AA, Lin YS, Nagar S, Paine MF. 2014. Herb-drug interactions: challenges and opportunities for improved predictions. Drug Metab Dispos. 42(3):301–317. doi: 10.1124/dmd.113.055236.
   PubMed Web of Science ®Google Scholar
• Brantley SJ, Gufford BT, Dua R, Fediuk DJ, Graf TN, Scarlett YV, Frederick KS, Fisher MB, Oberlies NH, Paine MF. 2014. Physiologically based pharmacokinetic modeling framework for quantitative prediction of an herb-drug interaction. CPT Pharmacometrics Syst Pharmacol. 3(3):e107. doi: 10.1038/psp.2013.69.
   PubMedGoogle Scholar
• Brinckmann J, Marles R, Schiff P, Oketch-Rabah H, Tirumalai G, Giancaspro G, Sarma N. 2020. Quality standards for botanicals. The legacy of USP’s 200 years of contributions. HerbalGram. 126:50–65.
   Google Scholar
• Brown NJ, Ryder D, Branch RA. 1990. A pharmacodynamic interaction between caffeine and phenylpropanolamine. Clin Pharmacol Ther. 50(4):363–371. doi: 10.1038/clpt.1991.152.
   Web of Science ®Google Scholar
• Campbell BI, Zito G, Colquhoun R, Martinez N, Kendall K, Buchanan L, Lehn M, Johnson M, St. Louis C, Smith Y, et al. 2016. The effects of a single-dose thermogenic supplement on resting metabolic rate and hemodynamic variables in healthy females – a randomized, double-blind, placebo-controlled, cross-over trial. J Int Soc Sports Nutr. 13(1):13. doi: 10.1186/s12970-016-0123-1.
   PubMedGoogle Scholar
• Chaplin A, Carpéné C, Mercader J. 2018. Resveratrol, metabolic syndrome, and gut microbiota. Nutrients. 10(11):1651. doi: 10.3390/nu10111651.
   PubMed Web of Science ®Google Scholar
• Cheema HA, Sohail A, Fatima A, Shahid A, Shahzil M, Rehman MEU, Awan RU, Chinnam S, Nashwan AJ. 2023. Quercetin for the treatment of COVID‐19 patients: a systematic review and meta‐analysis. Rev Med Virol. 33(2):e2427. doi: 10.1002/rmv.2427.
   PubMed Web of Science ®Google Scholar
• Chen M, Zhou SY, Fabriaga E, Zhang PH, Zhou Q. 2018. Food-drug interactions precipitated by fruit juices other than grapefruit juice: an update review. J Food Drug Anal. 26(2S):S61–S71. doi: 10.1016/j.jfda.2018.01.009.
   PubMedGoogle Scholar
• Cheng W, Xia K, Wu S, Li Y. 2023. Herb-drug interactions and their impact on pharmacokinetics: an update. Curr Drug Metab. 24(1):28–69. doi: 10.2174/1389200224666230116113240.
   PubMed Web of Science ®Google Scholar
• Choi JG, Eom SM, Kim J, Kim SH, Huh E, Kim H, Lee Y, Lee H, Oh MS. 2016. A comprehensive review of recent studies on herb-drug interaction: a focus on pharmacodynamic interaction. J Altern Complement Med. 22(4):262–279. doi: 10.1089/acm.2015.0235.
   PubMed Web of Science ®Google Scholar
• Chow HH, Garland LL, Hsu CH, Vining DR, Chew WM, Miller JA, Perloff M, Crowell JA, Alberts DS. 2010. Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev Res (Phila). 3(9):1168–1175. doi: 10.1158/1940-6207.CAPR-09-0155.
   PubMed Web of Science ®Google Scholar
• Cicero AFG, Baggioni A. 2016. Berberine and its role in chronic disease. Adv Exp Med Biol. 928:27–45. doi: 10.1007/978-3-319-41334-1_2.
   PubMed Web of Science ®Google Scholar
• Cnudde A, Watrin P, Souard F. 2022. HDI highlighter, the first intelligent tool to screen the literature on herb-drug interactions. Clin Pharmacokinet. 61(6):761–788. doi: 10.1007/s40262-022-01131-4.
   PubMed Web of Science ®Google Scholar
• Corroon J, Phillips JA. 2018. A cross-sectional study of cannabinol users. Cannabis Cannabinoid Res. 3(1):152–161. doi: 10.1089/can.2018.0006.
   PubMedGoogle Scholar
• Dietary Supplement Health and Education Act (DSHEA). 1994. Public Law 103-417, Act 42 U.S.C. 287C-11.
   Google Scholar
• Draves AH, Walker SE. 2003. Analysis of the hypericin and pseudohypericin content of commercially available St John’s Wort preparations. Can J Clin Pharmacol. 10(3):114–118.
   PubMedGoogle Scholar
• Dulloo AG, Seydoux J, Girardier L, Chantre P, Vandermander J. 2000. Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord. 24(2):252–258. doi: 10.1038/sj.ijo.0801101.
   PubMed Web of Science ®Google Scholar
• Federal Register. 2004. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Fed Reg. 69:6787–6854.
   PubMedGoogle Scholar
• Federal Register. 1988. Cold, cough, allergy, bronchodilator, and anti-asthmatic drug products for over-the-counter human use; tentative final monograph for combination drug products. Fed Reg. 53:30522–30564.
   Google Scholar
• Food and Drug Administration. 2011. Drug interaction studies – study design, data analysis, and implications for dosing and labeling. http://www.fda.gov/Drugs/.
   Google Scholar
• Foster L, Allan MC, Khan A, Moore P, Williams DK, Hubbard M, Dixon L, Gurley BJ. 2013. Multiple dosing of ephedra-free dietary supplements: hemodynamic, electrocardiographic, and bacterial contamination effects. Clin Pharmacol Ther. 93(3):267–274. doi: 10.1038/clpt.2012.241.
   PubMed Web of Science ®Google Scholar
• Gardiner P, Graham RE, Legedza AT, Eisenberg DM, Phillips RS. 2006. Factors associated with dietary supplement use among prescription medication users. Arch Intern Med. 166(18):1968–1974. doi: 10.1001/archinte.166.18.1968.
   PubMedGoogle Scholar
• Gödtel-Armbrust U, Metzger A, Kroll U, Kelber O, Wojnowski L. 2007. Variability in PXR-mediated induction of CYP3A4 by commercial preparations and dry extracts of St. John’s wort. Naunyn Schmiedebergs Arch Pharmacol. 375(6):377–382. doi: 10.1007/s00210-007-0172-8.
   PubMed Web of Science ®Google Scholar
• Golub V, Reddy DS. 2021. Cannabidiol therapy for refractory epilepsy and seizure disorders. Adv Exp Med Biol. 1264:93–110. doi: 10.1007/978-3-030-57369-0_7.
   PubMed Web of Science ®Google Scholar
• Guo Y, Chen Y, Tan ZR, Klaassen CD, Zhou HH. 2012. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. 68(2):213–217. doi: 10.1007/s00228-011-1108-2.
   PubMed Web of Science ®Google Scholar
• Gurley BJ. 2011. Emerging technologies for improving phytochemical bioavailability: benefits and risks. Clin Pharmacol Ther. 89(6):915–919. doi: 10.1038/clpt.2011.51.
   PubMed Web of Science ®Google Scholar
• Gurley BJ. 2012. Pharmacokinetic herb-drug interactions (Part 1): origins, mechanisms, and the impact of botanical dietary supplements. Planta Med. 78(13):1478–1489. doi: 10.1055/s-0031-1298273.
   PubMed Web of Science ®Google Scholar
• Gurley BJ, Fifer KE, Gardner Z. 2012. Pharmacokinetic herb-drug interactions (Part 2): drug interactions involving popular botanical dietary supplements and their clinical relevance. Planta Med. 78(13):1490–1514. doi: 10.1055/s-0031-1298331.
   PubMed Web of Science ®Google Scholar
• Gurley BJ, Gardner SF, Hubbard MA. 2000. Content versus label claims in ephedra-containing dietary supplements. Am J Health Syst Pharm. 57(10):963–969. doi: 10.1093/ajhp/57.10.963.
   PubMed Web of Science ®Google Scholar
• Gurley BJ, Markowitz JS, Williams DK, Barone GW. 2017. Practical considerations when designing and conducting clinical herb-drug interaction studies. Int J Pharmacokinet. 2(1):57–69. doi: 10.4155/ipk-2016-0009.
   Google Scholar
• Gurley BJ, Murphy TP, Gul W, Walker LA, ElSohly M. 2020. Content versus label claims in cannabidiol (CBD)-containing products obtained from commercial outlets in the state of Mississippi. J Diet Suppl. 17(5):599–607. doi: 10.1080/19390211.2020.1766634.
   PubMed Web of Science ®Google Scholar
• Gurley BJ, Steelman S, Thomas S. 2015. Multi-ingredient, caffeine-containing dietary supplements: history, safety, and efficacy. Clin Ther. 37(2):275–301. doi: 10.1016/j.clinthera.2014.08.012.
   PubMed Web of Science ®Google Scholar
• Gurley BJ, Tonsing-Carter A, Thomas SL, Fifer EK. 2018. Clinically relevant herb-micronutrient interactions: when botanicals, minerals, and vitamins collide. Adv Nutr. 9(4):524S–532S. doi: 10.1093/advances/nmy029.
   PubMed Web of Science ®Google Scholar
• Gurley BJ, Yates CR, Markowitz JS. 2018. “… Not intended to diagnose, treat, cure, or prevent any disease”: 25 years of botanical dietary supplement research and the lessons learned. Clin Pharmacol Ther. 104(3):470–483. doi: 10.1002/cpt.1131.
   PubMed Web of Science ®Google Scholar
• Hazekamp A. 2018. The trouble with CBD oil. Med Cannabis Cannabinoids. 1(1):65–72.
   PubMedGoogle Scholar
• Haller CA, Benowitz NL. 2000. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 343(25):1833–1838. doi: 10.1056/NEJM200012213432502.
   PubMed Web of Science ®Google Scholar
• Haller CA, Benowitz NL, Jacob P. 2005. Hemodynamic effects of ephedra-free weight-loss supplements in humans. Am J Med. 118(9):998–1003. doi: 10.1016/j.amjmed.2005.02.034.
   PubMed Web of Science ®Google Scholar
• Haller CA, Jacob P, Benowitz NL. 2002. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin Pharmacol Ther. 71(6):421–432. doi: 10.1067/mcp.2002.124523.
   PubMed Web of Science ®Google Scholar
• Haller CA, Jacob P, Benowitz NL. 2005. Short-term metabolic and hemodynamic effects of ephedra and guarana combinations. Clin Pharmacol Ther. 77(6):560–571. doi: 10.1016/j.clpt.2005.01.023.
   PubMed Web of Science ®Google Scholar
• Hanley MJ, Cancalon P, Widmer WW, Greenblatt DJ. 2011. The effect of grapefruit juice on drug disposition. Expert Opin Drug Metab Toxicol. 7(3):267–286. doi: 10.1517/17425255.2011.553189.
   PubMed Web of Science ®Google Scholar
• Harty PS, Zabriskie HA, Erickson JL, Molling PE, Kerksick CM, Jagim AR. 2018. Multi-ingredient pre-workout supplements, safety implications, and performance outcomes: a brief review. J Int Soc Sports Nutr. 15(1):41. doi: 10.1186/s12970-018-0247-6.
   PubMed Web of Science ®Google Scholar
• Hodgson E, Philpot RM. 1974. Interaction of methylenedioxyphenyl (1,3-benzodioxole compounds with enzymes and their effects on mammals. Drug Metab Rev. 3(2):231–301. doi: 10.3109/03602537408993744.
   PubMed Web of Science ®Google Scholar
• Hypericum Depression Trial Study Group. 2002. Effect of Hypericum perforatum (St John’s wort) in major depressive disorder: a randomized controlled trial. JAMA. 287(14):1807–1814. doi: 10.1001/jama.287.14.1807.
   PubMed Web of Science ®Google Scholar
• Imenshahidi M, Hosseinzadeh H. 2016. Berberis vulgaris and berberine: an update review. Phytother Res. 30(11):1745–1764. doi: 10.1002/ptr.5693.
   PubMed Web of Science ®Google Scholar
• Inayat F, Majeed CN, Ali NS, Hayat M, Vasim I. 2018. The risky side of weight-loss dietary supplements: disrupting arrhythmias causing sudden cardiac arrest. BMJ Case Rep. 11(1):e227531. doi: 10.1136/bcr-2018-227531.
   PubMedGoogle Scholar
• Izzo AA, Di Carlo G, Borrelli F, Ernst E. 2005. Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction. Int J Cardiol. 98(1):1–14. doi: 10.1016/j.ijcard.2003.06.039.
   PubMed Web of Science ®Google Scholar
• Jagim AR, Camic CL, Harty PS. 2019. Common habits, adverse events, and 0pinions regarding pre-workout supplement use among regular consumers. Nutrients. 11(4):855. doi: 10.3390/nu11040855.
   PubMed Web of Science ®Google Scholar
• Jedrejko K, Lazur J, Muszynska B. 2021. Risk associated with the use of selected ingredients in food supplements. Chem Biodiver. 18:e2000686.
   PubMed Web of Science ®Google Scholar
• Jiang W, Wang X, Xu X, Kong L. 2010. Effect of Schisandra sphenanthera extract on the concentration of tacrolimus in the blood of liver transplant patients. Int J Clin Pharmacol Ther. 48(3):224–229. doi: 10.5414/cpp48224.
   PubMed Web of Science ®Google Scholar
• Johnson E, Kilgore M, Babalonis S. 2022. Label accuracy of unregulated cannabidiol (CBD) products: measured content vs. label claim. J Cannabis Res. 4(1):28. doi: 10.1186/s42238-022-00140-1.
   PubMedGoogle Scholar
• Jung YP, Earnest CP, Koozehchian M, Galvan E, Dalton R, Walker D, Rasmussen C, Murano PS, Greenwood M, Kreider RB. 2017. Effects of acute ingestion of a pre-workout dietary supplement with and without p- synephrine on resting energy expenditure, cognitive function and exercise performance. J Int Soc Sports Nutr. 14(1):3. doi: 10.1186/s12970-016-0159-2.
   PubMedGoogle Scholar
• Kantor ED, Rehm CD, Du M, White E, Giovannucci EL. 2016. Trends in dietary supplement use among adults from 1999-2012. JAMA. 316(14):1464–1474. doi: 10.1001/jama.2016.14403.
   PubMed Web of Science ®Google Scholar
• Kedia AW, Hofheins JE, Habowski SM, Ferrando AA, Gothard MD, Lopez HL. 2014. Effects of a pre-workout supplement on lean mass, muscular performance, subjective workout experience and biomarkers of safety. Int J Med Sci. 11(2):116–126. doi: 10.7150/ijms.7073.
   PubMed Web of Science ®Google Scholar
• Kesarwani K, Gupta R, Mukerjee A. 2013. Bioavailability enhancers of herbal origin: an overview. Asian Pac J Trop Biomed. 3(4):253–266. doi: 10.1016/S2221-1691(13)60060-X.
   PubMedGoogle Scholar
• Kim TE, Shin KH, Park JE, Kim MG, Yun YM, Choi DH, Kwon KJ, Lee J. 2018. Effect of green tea catechins on the pharmacokinetics of digoxin in humans. Drug Des Devel Ther. 12:2139–2147. doi: 10.2147/DDDT.S148257.
   PubMed Web of Science ®Google Scholar
• Knapik JJ, Trone DW, Steelman RA, Farina EK, Lieberman HR. 2022. Adverse effects associated with use of specific dietary supplements: the US Military Dietary Supplement Use Study. Food Chem Toxicol. 161:112840. doi: 10.1016/j.fct.2022.112840.
   PubMed Web of Science ®Google Scholar
• Knop J, Misaka S, Singer K, Hoier E, Müller F, Glaeser H, König J, Fromm MF. 2015. Inhibitory effects of green tea and (-)-epigallocatechin gallate on transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-glycoprotein. PLoS One. 10(10):e0139370. eCollection 2015. doi: 10.1371/journal.pone.0139370.
   PubMed Web of Science ®Google Scholar
• Koncic MZ, Tomczyk M. 2013. New insights into dietary supplements used in sport: active substances, pharmacological and side effects. Curr Drug Targets. 14(9):1079–1092. doi: 10.2174/1389450111314090016.
   PubMed Web of Science ®Google Scholar
• Lake CR, Quirk RS. 1984. CNS stimulants and the look-alike drugs. Psychiatr Clin North Am. 19(1):21–31.
   Google Scholar
• Lattanzi S, Trinka E, Striano P, Zaccara G, Del Giovane C, Nardone R, Silvestrini M, Brigo F. 2020. Cannabidiol efficacy and clobazam status: a systematic review and meta-analysis. Epilepsia. 61(6):1090–1098. doi: 10.1111/epi.16546.
   PubMed Web of Science ®Google Scholar
• Lee SH, Kim HY, Back SY, Han HK. 2018. Piperine-mediated drug interactions and formulation strategy for piperine: recent advances and future perspectives. Expert Opin Drug Metab Toxicol. 14(1):43–57. doi: 10.1080/17425255.2018.1418854.
   PubMed Web of Science ®Google Scholar
• Lehmann EL. 1993. The Fisher, Neyman-Pearson theories of testing hypotheses: one theory or two? J Am Stat Assoc. 88(424):1242–1249. doi: 10.2307/2291263.
   Web of Science ®Google Scholar
• Liebling JP, Clarkson NJ, Gibbs BW, Yates AS, O’Sullivan SE. 2022. An analysis of over-the-counter cannabidiol products in the United Kingdom. Cannabis Cannabinoid Res. 7(2):207–213. doi: 10.1089/can.2019.0078.
   PubMedGoogle Scholar
• Linde K, Berner MM, Kriston L. 2008. St John’s wort for major depression. Cochrane Database Syst Rev. 2008(4):CD000448. doi: 10.1002/14651858.CD000448.pub3.
   PubMedGoogle Scholar
• Loughren MJ, Kharasch ED, Kelton-Rehkopf MC, Syrjala KL, Shen DD. 2020. Influence of St. John’s Wort on intravenous fentanyl pharmacokinetics, pharmacodynamics, and clinical effects: a randomized clinical trial. Anesthesiology. 132(3):491–503. doi: 10.1097/ALN.0000000000003065.
   PubMed Web of Science ®Google Scholar
• Madabushi R, Frank B, Drewelow B, Derendorf H, Butterweck V. 2006. Hyperforin in St. John’s wort interactions. Eur J Clin Pharmacol. 62(3):225–233. doi: 10.1007/s00228-006-0096-0.
   PubMed Web of Science ®Google Scholar
• Mai I, Störmer E, Bauer S, Krüger H, Budde K, Roots I. 2003. Impact of St John’s wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients. Nephrol Dial Transplant. 18(4):819–822. doi: 10.1093/ndt/gfg002.
   PubMed Web of Science ®Google Scholar
• Makkar HPS, Siddhuraju P, Becker K. 2007. Plant secondary metabolites. Totowa (NJ): Humana Press.
   Google Scholar
• Marcus DM, Grollman AP. 2003. Ephedra-free is not danger free. Science. 301(5640):1669–1671. doi: 10.1126/science.301.5640.1669c.
   PubMed Web of Science ®Google Scholar
• Markowitz JS, De Faria L, Zhang Q, Melchert PW, Frye RF, Klee BO, Qian Y. 2022. The influence of cannabidiol on the pharmacokinetics of methylphenidate in healthy subjects. Med Cannabis Cannabinoids. 5(1):199–206. doi: 10.1159/000527189.
   PubMedGoogle Scholar
• Markowitz JS, von Moltke LL, Donovan JL. 2008. Predicting interactions between conventional medications and botanical products on the basis of in vitro investigations. Mol Nutr Food Res. 52(7):747–754. doi: 10.1002/mnfr.200700159.
   PubMed Web of Science ®Google Scholar
• Markowitz JS, Zhu HJ. 2012. Limitations of in vitro assessments of the drug interaction potential of botanical supplements. Planta Med. 78(13):1421–1427. doi: 10.1055/s-0032-1315025.
   PubMed Web of Science ®Google Scholar
• Mead A. 2019. Legal and regulatory issues governing Cannabis and Cannabis-derived products in the United State. Front Plant Sci. 10:697. doi: 10.3389/fpls.2019.00697.
   PubMed Web of Science ®Google Scholar
• Mehta DH, Gardiner PM, Phillips RS, McCarthy EP. 2008. Herbal and dietary supplement disclosure to health care providers by individuals with chronic conditions. J Altern Complement Med. 14(10):1263–1269. doi: 10.1089/acm.2008.0290.
   PubMed Web of Science ®Google Scholar
• Min B, McBride BF, Kardas MJ, Ismali A, Sinha V, Kluger J, White CM. 2005a. Electrocardiographic effects of an Ephedra-free, multicomponent weight-loss supplement in healthy volunteers. Pharmacotherapy. 25(5):654–659. doi: 10.1592/phco.25.5.654.63581.
   PubMed Web of Science ®Google Scholar
• Min B, McBride BF, Kardas MJ, Ismali A, Sinha V, Kluger J, White CM. 2005b. Hemodynamic impact of an Ephedra-free multicomponent weight-loss supplement. Am J Health Syst Pharm. 62(15):1582–1585. doi: 10.2146/ajhp040538.
   PubMed Web of Science ®Google Scholar
• Misaka S, Yatabe J, Müller F, Takano K, Kawabe K, Glaeser H, Yatabe MS, Onoue S, Werba JP, Watanabe H, et al. 2014. Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects. Clin Pharmacol Ther. 95(4):432–438. doi: 10.1038/clpt.2013.241.
   PubMed Web of Science ®Google Scholar
• Moaddeb J, Tofade TS, Bevins MB. 2011. Hypertensive urgency associated with Xenadrine EFX use. J Pharm Pract. 24(4):400–403. doi: 10.1177/0897190011406127.
   Google Scholar
• Moore LB, Goodwin B, Jones SA, Wisely WB, Serabjit-Singh CJ, Willson TM, Collins JL, Kliewer SA. 2000. St John’s wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA. 97(13):7500–7502. doi: 10.1073/pnas.130155097.
   PubMed Web of Science ®Google Scholar
• Mueller SC, Majcher-Peszynska J, Uehleke B, Klammt S, Mundkowski RG, Miekisch W, Sievers H, Bauer S, Frank B, Kundt G, et al. 2006. The extent of induction of CYP3A by St. John’s wort varies among products and is linked to hyperforin dose. Eur J Clin Pharmacol. 62(1):29–36. doi: 10.1007/s00228-005-0061-3.
   PubMed Web of Science ®Google Scholar
• Murray M. 2000. Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation. Curr Drug Metab. 1(1):67–84. doi: 10.2174/1389200003339270.
   PubMed Web of Science ®Google Scholar
• Murray M. 2012. Toxicological actions of plant-derived and anthropogenic methy­lenedioxyphenyl-substituted chemicals in mammals and insects. J Toxicol Environ Health B Crit Rev. 15(6):365–395. doi: 10.1080/10937404.2012.705105.
   PubMed Web of Science ®Google Scholar
• Murtaza G, Ullah N, Mukhtar F, Nawazish S, Muneer S, Mariam. 2017. Phytotherapeutics: the emerging role of intestinal and hepatocellular transporters in drug interactions with botanical supplements. Molecules. 22(10):1699. doi: 10.3390/molecules22101699.
   PubMed Web of Science ®Google Scholar
• Nazari S, Rameshrad M, Hosseinzadeh H. 2017. Toxicological effects of Glycyrrhiza glabra (Licorice): a review. Phytother Res. 31(11):1635–1650. doi: 10.1002/ptr.5893.
   PubMed Web of Science ®Google Scholar
• Ng JY, Munford V, Thakar H. 2020. Web-based online resources about adverse interactions or side effects associated with complementary and alternative medicine: a systematic review, summarization and quality assessment. BMC Med Inform Decis Mak. 20(1):290. doi: 10.1186/s12911-020-01298-5.
   PubMed Web of Science ®Google Scholar
• Nguyen JT, Tian D-D, Tanna RS, Hadi DL, Bansal S, Calamia JC, Arian CM, Shireman LM, Molnár B, Horváth M, et al. 2021. Assessing transporter-mediated natural product-drug interactions via in vitro-in vivo extrapolation: clinical evaluation with a probe cocktail. Clin Pharmacol Ther. 109(5):1342–1352. doi: 10.1002/cpt.2107.
   PubMed Web of Science ®Google Scholar
• Nicolussi S, Drewe J, Butterweck V, Meyer zu Schwabedissen HE. 2020. Clinical relevance of St. John’s wort drug interactions revisited. Br J Pharmacol. 177(6):1212–1226. doi: 10.1111/bph.14936.
   PubMed Web of Science ®Google Scholar
• Oketch-Rabah HA, Hardy ML, Patton AP, Chung M, Sarma ND, Yoe C, Ayyadurai VAS, Fox MA, Jordan SA, Mwamburi M, et al. 2021. Multi-criteria decision analysis model for assessing the risk from multi-ingredient dietary supplements (MIDS). J Diet Suppl. 18(3):293–315. doi: 10.1080/19390211.2020.1741485.
   PubMed Web of Science ®Google Scholar
• Pagano C, Navarra G, Coppola L, Avilia G, Bifulco M, Laezza C. 2022. Cannabinoids: therapeutic use in clinical practice. Int J Mol Sci. 23(6):3344. doi: 10.3390/ijms23063344.
   PubMed Web of Science ®Google Scholar
• Panossian AG. 2013. Adaptogens in mental and behavioral disorders. Psychiatr Clin North Am. 36(1):49–64. doi: 10.1016/j.psc.2012.12.005.
   PubMed Web of Science ®Google Scholar
• Pavlovic R, Nenna G, Calvi L, Panseri S, Borgonovo G, Giupponi L, Cannazza G, Giorgi A. 2018. Quality traits of "cannabidiol oils": cannabinoids content, terpene fingerprint and oxidation stability of European commercially available preparations. Molecules. 23(5):1230. doi: 10.3390/molecules23051230.
   PubMed Web of Science ®Google Scholar
• Pawar A, Russo M, Rani I, Goswami K, Russo GL, Pal A. 2022. A critical evaluation of risk to reward ratio of quercetin supplementation for COVID-19 and associated comorbid conditions. Phytother Res. 36(6):2394–2415. doi: 10.1002/ptr.7461.
   PubMed Web of Science ®Google Scholar
• Posadzki P, Watson L, Ernst E. 2013. Herb-drug interactions: an overview of systematic reviews. Br J Clin Pharmacol. 75(3):603–618. doi: 10.1111/j.1365-2125.2012.04350.x.
   PubMed Web of Science ®Google Scholar
• Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. 2008. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 300(24):2867–2878. doi: 10.1001/jama.2008.892.
   PubMed Web of Science ®Google Scholar
• Qian Y, Gurley BJ, Markowitz JS. 2019. The potential for pharmacokinetic interactions between Cannabis products and conventional medications. J Clin Psychopharmacol. 39(5):462–471. doi: 10.1097/JCP.0000000000001089.
   PubMed Web of Science ®Google Scholar
• Rauf A, Imran M, Khan IA, Ur-Rehman M, Gilani SA, Mehmood Z, Mubarak MS. 2018. Anticancer potential of quercetin: a comprehensive review. Phytother Res. 32(11):2109–2130. doi: 10.1002/ptr.6155.
   PubMed Web of Science ®Google Scholar
• Ruschitzka F, Meier PJ, Turina M, Lüscher TF, Noll G. 2000. Acute heart transplant rejection due to Saint John’s wort. Lancet. 355(9203):548–549. doi: 10.1016/S0140-6736(99)05467-7.
   PubMed Web of Science ®Google Scholar
• Russo E, Scicchitano F, Whalley BJ, Mazzitello C, Ciriaco M, Esposito S, Patanè M, Upton R, Pugliese M, Chimirri S, et al. 2014. Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions. Phytother Res. 28(5):643–655. doi: 10.1002/ptr.5050.
   PubMed Web of Science ®Google Scholar
• Saeed M, Naveed M, Arif M, Kakar MU, Manzoor R, Abd El-Hack ME, Alagawany M, Tiwari R, Khandia R, Munjal A, et al. 2017. Green tea (Camellia sinensis) and l-theanine: medicinal values and beneficial applications in humans – a comprehensive review. Biomed Pharmacother. 95:1260–1275. doi: 10.1016/j.biopha.2017.09.024.
   PubMed Web of Science ®Google Scholar
• Saper RB, Eisenberg DM, Phillips RS. 2004. Common dietary supplements for weight loss. Am Fam Physician. 70(9):1731–1738.
   PubMed Web of Science ®Google Scholar
• Scholl C, Lepper A, Lehr T, Hanke N, Schneider KL, Brockmöller J, Seufferlein T, Stingl JC. 2018. Population nutrikinetics of green tea extract. PLoS One. 13(2):e0193074. doi: 10.1371/journal.pone.0193074.eCollection.2018.
   PubMed Web of Science ®Google Scholar
• Schwarz NA, McKinley-Barnard SK, Blahnik ZJ. 2019. Effect of Bang® Pre-Workout Master Blaster® combined with four weeks of resistance training on lean body mass, maximal strength, mircoRNA expression, and serum IGF-1 in men: a randomized, double-blind, placebo-controlled trial. J Int Soc Sports Nutr. 16(1):54. doi: 10.1186/s12970-019-0310-y.
   PubMed Web of Science ®Google Scholar
• Shi S, Klotz U. 2012. Drug interactions with herbal medicines. Clin Pharmacokinet. 51(2):77–104. doi: 10.2165/11597910-000000000-00000.
   PubMed Web of Science ®Google Scholar
• Sprouse AA, van Breemen RB. 2016. Pharmacokinetic interactions between drugs and botanical dietary supplements. Drug Metab Dispos. 44(2):162–171. doi: 10.1124/dmd.115.066902.
   PubMed Web of Science ®Google Scholar
• Sterne JAC, Smith GD. 2001. Sifting the evidence – what’s wrong with significance tests. BMJ. 322(7280):226–231. doi: 10.1136/bmj.322.7280.226.
   PubMed Web of Science ®Google Scholar
• Stieger B, Mahdi ZM, Jäger W. 2017. Intestinal and hepatocellular transporters: therapeutic effects and drug interactions of herbal supplements. Annu Rev Pharmacol Toxicol. 57:399–416. doi: 10.1146/annurev-pharmtox-010716-105010.
   PubMed Web of Science ®Google Scholar
• Stout SM, Cimino NM. 2014. Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review. Drug Metab Rev. 46(1):86–95. doi: 10.3109/03602532.2013.849268.
   PubMed Web of Science ®Google Scholar
• Waidyanatha S, Ryan K, Roe AL, Jia W, Paine MF, Ferguson S, Gurley BJ, Welch K, Chow MSS, Devito M, et al. 2018. Follow that botanical: challenges and recommendations for assessing absorption, distribution, metabolism and excretion of botanical dietary supplements. Food Chem Toxicol. 121:194–202. doi: 10.1016/j.fct.2018.08.062.
   PubMed Web of Science ®Google Scholar
• Wang SSY. 2020. Pre-workout supplement induced cardiac ischaemia in a young female. J Sports Sci. 38(2):187–191. doi: 10.1080/02640414.2019.1689598.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang H, Chen L, Shan L, Fan G, Gao X. 2013. Liquorice, a unique “guide drug” of traditional Chinese medicine: a review of its role in drug interactions. J Ethnopharmacol. 150(3):781–790. doi: 10.1016/j.jep.2013.09.055.
   PubMed Web of Science ®Google Scholar
• Watkins RE, Maglich JM, Moore LB, Wisely GB, Noble SM, Davis-Searles PR, Lambert MH, Kliewer SA, Redinbo MR. 2003. 2.1 Å crystal structure of human PXR in complex with the St John’s wort compound hyperforin. Biochemistry. 42(6):1430–1438. doi: 10.1021/bi0268753.
   PubMed Web of Science ®Google Scholar
• Wentworth JM, Agostini M, Love J, Schwabe JW, Chatterjee VKK. 2000. St John’s wort, a herbal antidepressant, activates the steroid X receptor. J Endocrinol. 166(3):R11–R16. doi: 10.1677/joe.0.166r011.
   PubMed Web of Science ®Google Scholar
• Werba JP, Misaka S, Giroli MG, Yamada S, Cavalca V, Kawabe K, Squellerio I, Laguzzi F, Onoue S, Veglia F, et al. 2015. Overview of green tea interaction with cardiovascular drugs. Curr Pharm Des. 21(9):1213–1219. doi: 10.2174/1381612820666141013135045.
   PubMed Web of Science ®Google Scholar
• Whitten DL, Myers SP, Hawrelak JA, Wohlmuth H. 2006. The effect of St. John’s wort extract on CYP3A: a systematic review of prospective clinical trials. Br J Clin Pharmacol. 62(5):512–526. doi: 10.1111/j.1365-2125.2006.02755.x.
   PubMed Web of Science ®Google Scholar
• Wold RS, Lopez ST, Yau L, Butler LM, Pareo-Tubbeh SL, Waters DL, Garry PJ, Baumgartner RN. 2005. Increasing trends in elderly persons’ use of nonvitamin, nonmineral dietary supplements and concurrent use of medications. J Am Diet Assoc. 105(1):54–63. doi: 10.1016/j.jada.2004.11.002.
   PubMed Web of Science ®Google Scholar
• Wu X, Li Q, Xin H, Yu A, Zhong M. 2005. Effects of berberine on the blood concentration of cyclosporine A in renal transplanted recipients: clinical and pharmacokinetic study. Eur J Clin Pharmacol. 61(8):567–572. doi: 10.1007/s00228-005-0952-3.
   PubMed Web of Science ®Google Scholar
• Young R, Gabryszuk M, Glennon RA. 1998. (–)Ephedrine and caffeine mutually potentiate one another’s amphetamine-like stimulus effects. Pharmacol Biochem Behav. 61(2):169–173. doi: 10.1016/s0091-3057(98)00044-6.
   PubMed Web of Science ®Google Scholar
• Zhou S-F, Lai X. 2008. An update on clinical drug interactions with the herbal antidepressant St John’s wort. Curr Drug Metab. 9(5):394–409. doi: 10.2174/138920008784746391.
   PubMed Web of Science ®Google Scholar